260 related articles for article (PubMed ID: 30056057)
1. Endothelial function and dysfunction: Impact of metformin.
Nafisa A; Gray SG; Cao Y; Wang T; Xu S; Wattoo FH; Barras M; Cohen N; Kamato D; Little PJ
Pharmacol Ther; 2018 Dec; 192():150-162. PubMed ID: 30056057
[TBL] [Abstract][Full Text] [Related]
2. Metformin Prevents Hyperglycemia-Associated, Oxidative Stress-Induced Vascular Endothelial Dysfunction: Essential Role for the Orphan Nuclear Receptor Human Nuclear Receptor 4A1 (Nur77).
Venu VKP; Saifeddine M; Mihara K; Faiza M; Gorobets E; Flewelling AJ; Derksen DJ; Hirota SA; Marei I; Al-Majid D; Motahhary M; Ding H; Triggle CR; Hollenberg MD
Mol Pharmacol; 2021 Nov; 100(5):428-455. PubMed ID: 34452975
[TBL] [Abstract][Full Text] [Related]
3. Metformin effects on the heart and the cardiovascular system: A review of experimental and clinical data.
Nesti L; Natali A
Nutr Metab Cardiovasc Dis; 2017 Aug; 27(8):657-669. PubMed ID: 28709719
[TBL] [Abstract][Full Text] [Related]
4. An investigation into the pleiotropic activity of metformin. A glimpse of haemostasis.
Markowicz-Piasecka M; Sadkowska A; Huttunen KM; Podsiedlik M; Mikiciuk-Olasik E; Sikora J
Eur J Pharmacol; 2020 Apr; 872():172984. PubMed ID: 32017937
[TBL] [Abstract][Full Text] [Related]
5. Metformin improves endothelial function in aortic tissue and microvascular endothelial cells subjected to diabetic hyperglycaemic conditions.
Ghosh S; Lakshmanan AP; Hwang MJ; Kubba H; Mushannen A; Triggle CR; Ding H
Biochem Pharmacol; 2015 Dec; 98(3):412-21. PubMed ID: 26467186
[TBL] [Abstract][Full Text] [Related]
6. Impact of currently used anti-diabetic drugs on myoendothelial communication.
Ding H; Ye K; Triggle CR
Curr Opin Pharmacol; 2019 Apr; 45():1-7. PubMed ID: 30502742
[TBL] [Abstract][Full Text] [Related]
7. Metformin improves endothelial function in patients with metabolic syndrome.
Vitale C; Mercuro G; Cornoldi A; Fini M; Volterrani M; Rosano GM
J Intern Med; 2005 Sep; 258(3):250-6. PubMed ID: 16115299
[TBL] [Abstract][Full Text] [Related]
8. Improved endothelial function with metformin in type 2 diabetes mellitus.
Mather KJ; Verma S; Anderson TJ
J Am Coll Cardiol; 2001 Apr; 37(5):1344-50. PubMed ID: 11300445
[TBL] [Abstract][Full Text] [Related]
9. [Molecular action of insulin-sensitizing agents].
Kacalska O; Krzyczkowska-Sendrakowska M; Milewicz T; Zabińska-Popiela M; Bereza T; Krzysiek-Maczka G; Krzysiek J
Endokrynol Pol; 2005; 56(3):308-13. PubMed ID: 16350724
[TBL] [Abstract][Full Text] [Related]
10. AMPK activation as a strategy for reversing the endothelial lipotoxicity underlying the increased vascular risk associated with insulin resistance syndrome.
McCarty MF
Med Hypotheses; 2005; 64(6):1211-5. PubMed ID: 15823720
[TBL] [Abstract][Full Text] [Related]
11. Protective effects of metformin in various cardiovascular diseases: Clinical evidence and AMPK-dependent mechanisms.
Bu Y; Peng M; Tang X; Xu X; Wu Y; Chen AF; Yang X
J Cell Mol Med; 2022 Oct; 26(19):4886-4903. PubMed ID: 36052760
[TBL] [Abstract][Full Text] [Related]
12. Metformin is not just an antihyperglycaemic drug but also has protective effects on the vascular endothelium.
Triggle CR; Ding H
Acta Physiol (Oxf); 2017 Jan; 219(1):138-151. PubMed ID: 26680745
[TBL] [Abstract][Full Text] [Related]
13. Metformin improves endothelial vascular reactivity in first-degree relatives of type 2 diabetic patients with metabolic syndrome and normal glucose tolerance.
de Aguiar LG; Bahia LR; Villela N; Laflor C; Sicuro F; Wiernsperger N; Bottino D; Bouskela E
Diabetes Care; 2006 May; 29(5):1083-9. PubMed ID: 16644641
[TBL] [Abstract][Full Text] [Related]
14. Does drug therapy reverse endothelial progenitor cell dysfunction in diabetes?
Desouza CV
J Diabetes Complications; 2013; 27(5):519-25. PubMed ID: 23809765
[TBL] [Abstract][Full Text] [Related]
15. A reappraisal on metformin.
Adak T; Samadi A; Ünal AZ; Sabuncuoğlu S
Regul Toxicol Pharmacol; 2018 Feb; 92():324-332. PubMed ID: 29291990
[TBL] [Abstract][Full Text] [Related]
16. Metformin: An old drug against old age and associated morbidities.
Salvatore T; Pafundi PC; Morgillo F; Di Liello R; Galiero R; Nevola R; Marfella R; Monaco L; Rinaldi L; Adinolfi LE; Sasso FC
Diabetes Res Clin Pract; 2020 Feb; 160():108025. PubMed ID: 31954752
[TBL] [Abstract][Full Text] [Related]
17. Metformin reduces arterial stiffness and improves endothelial function in young women with polycystic ovary syndrome: a randomized, placebo-controlled, crossover trial.
Agarwal N; Rice SP; Bolusani H; Luzio SD; Dunseath G; Ludgate M; Rees DA
J Clin Endocrinol Metab; 2010 Feb; 95(2):722-30. PubMed ID: 19996308
[TBL] [Abstract][Full Text] [Related]
18. Metformin: diamonds are forever.
Papanas N; Maltezos E; Mikhailidis DP
Expert Opin Pharmacother; 2009 Oct; 10(15):2395-7. PubMed ID: 19678795
[TBL] [Abstract][Full Text] [Related]
19. Impact of metformin on endothelial ischemia-reperfusion injury in humans in vivo: a prospective randomized open, blinded-endpoint study.
El Messaoudi S; Schreuder TH; Kengen RD; Rongen GA; van den Broek PH; Thijssen DH; Riksen NP
PLoS One; 2014; 9(4):e96062. PubMed ID: 24755906
[TBL] [Abstract][Full Text] [Related]
20. Metformin protects endothelial function in diet-induced obese mice by inhibition of endoplasmic reticulum stress through 5' adenosine monophosphate-activated protein kinase-peroxisome proliferator-activated receptor δ pathway.
Cheang WS; Tian XY; Wong WT; Lau CW; Lee SS; Chen ZY; Yao X; Wang N; Huang Y
Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):830-6. PubMed ID: 24482374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
